Teoh, E., Bridges, E., Morotti, M., Zois, C., Lord, S., Gleeson, F., & Harris, A. (2017). Fluciclovine is a potential imaging biomarker of glutamine utilisation in breast cancer. Springer.
Citación estilo ChicagoTeoh, EJ, EM Bridges, M. Morotti, CE Zois, SR Lord, FV Gleeson, and AL Harris. Fluciclovine Is a Potential Imaging Biomarker of Glutamine Utilisation in Breast Cancer. Springer, 2017.
Cita MLATeoh, EJ, et al. Fluciclovine Is a Potential Imaging Biomarker of Glutamine Utilisation in Breast Cancer. Springer, 2017.
Warning: These citations may not always be 100% accurate.